Results

Total Results: 705 records

Showing results for "drugs".

261. References | Agency for Healthcare Research and Quality
     www.qualitymeasures.ahrq.gov/pqmp/implementation-qi/toolkit/antipsychotic/references.html
     July 01, 2021 - National trends in the outpatient treatment of children and adolescents with antipsychotic drugs.

262. Blood Pressure Control Evidence and Resources | Agency for Healthcare Research and Quality
     www.qualitymeasures.ahrq.gov/evidencenow/projects/heart-health/evidence/blood-pressure.html
     March 01, 2021 - medications used to treat high blood pressure and includes generic and brand names for all FDA-approved drugs

263. Chapter 3. Risk-Informed Interventions | Agency for Healthcare Research and Quality
     www.qualitymeasures.ahrq.gov/research/findings/final-reports/stpra/stpra3.html
     April 01, 2018 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

264. Tool 5: How To Conduct a Postdischarge Followup Phone Call | Agency for Healthcare Research and Quality
     www.qualitymeasures.ahrq.gov/patient-safety/settings/hospital/red/toolkit/redtool5.html
     March 01, 2013 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

265. Resources | Agency for Healthcare Research and Quality
     www.qualitymeasures.ahrq.gov/health-literacy/professional-training/pharmacy/resources.html
     September 01, 2020 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

266. Study Finds Patients Who Self-Test Negative for COVID-19 Not Properly Quarantining | Agency for Healthcare Research and Quality
     www.qualitymeasures.ahrq.gov/news/newsletters/e-newsletter/821.html
     June 01, 2022 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

267. Strategy 6D: Internet Access for Health Information and Advice | Agency for Healthcare Research and Quality
     www.qualitymeasures.ahrq.gov/cahps/quality-improvement/improvement-guide/6-strategies-for-improving/access/strategy6d-internet.html
     April 01, 2023 - Problem Many health care consumers seek information about specific complaints, conditions or diseases, drugs

268. Global Assessment of Pediatric Patient Safety (GAPPS) Trigger Tool (pdf file)
     www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-143-fullreport.pdf
     April 01, 2018 - Global Assessment of Pediatric Patient Safety (GAPPS) Trigger Tool 1 Global Assessment of Pediatric Patient Safety (GAPPS) Trigger Tool Section 1. Basic Measure Information 1.A. Measure Name Global Assessment of Pediatric Patient Safety (GAPPS) Trigger Tool 1.B. Measure Number 0143 1.C. Measure Description …

269. Value Set Export (xls file)
     www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/0085behaviorcoding.xls
     January 01, 2012 - Value Set Export Disclaimer Copyright 2012 American Medical Association and National Committee for Quality Assurance. All Rights Reserved. Physician Performance Measures (Measures) and related data specifications have been developed by the American Medical Association (AMA) - convened Physician Consortium for Perfor…

270. Final Topic Refinement Document - Therapeutic Options for Obesity in the Medicare Population (pdf file)
     www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/obesity_topic-refinement.pdf
     May 22, 2014 - Final Topic Refinement Document - Therapeutic Options for Obesity in the Medicare Population Final Topic Refinement Document Therapeutic Options for Obesity in the Medicare Population (ID: OBET0913) May 22, 2014 AHRQ Technology Assessment Program Johns Hopkins University Evidence-based Practice Center …

271. 2019 National Healthcare Quality and Disparities Report Data Sources (pdf file)
     www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2019qdr-datasources.pdf
     December 01, 2020 - are collected from medical records and include type of provider seen; reason for visit; diagnoses; drugs … characteristics; age at first use, lifetime, past-year, and past-month use of the following substances: illicit drugs

272. Use of Multiple Concurrent Antipsychotics in Children (pdf file)
     www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-126-fullreport.pdf
     May 01, 2018 - Medicaid from 2002-2007 and saw that both overall psychoactive use and polypharmacy of psychoactive drugs … National trends in the outpatient treatment of children and adolescents with antipsychotic drugs.

273. PBRN Registry Search | Agency for Healthcare Research and Quality
     www.qualitymeasures.ahrq.gov/ncepcr/communities/pbrn/registry/index.html?page=3
     March 25, 2024 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

274. Chapter 4. Long Term Management | Agency for Healthcare Research and Quality
     www.qualitymeasures.ahrq.gov/patient-safety/settings/long-term-care/resource/injuries/fallspx/man4.html
     December 01, 2017 - all medications should be reviewed for their potential impact on fall risk, the following classes of drugs … Please go to the Falls Assessment Cue Sheet for a list of the drugs in each class.

275. Creating a Safe Medicine List: Patient Information/Reminder Flyer (pdf file)
     www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-family-engagement/pfeprimarycare/medicinelist-patient-flier-final508.pdf
     April 12, 2018 - Creating a Safe Medicine List: Patient Information/Reminder Flyer Please Bring ALL Your Medicines to Your Next Appointment To keep you safe, we need to know about all the medicine you take from all your doctors. Please make sure you bring (in the original container)... � Prescription medicines. � Medicines you …

276. CAHPS Cancer Care Supplemental Items (doc file)
     www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/cahps/surveys-guidance/cancer/suppl-items-cancer-sdm-english-557-5a.docx
     March 07, 2017 - CAHPS Cancer Care Supplemental Items CAHPS® Cancer Care Survey Supplemental Items: Shared Decision Making Population: Adult Supplemental Items for the CAHPS® Cancer Care Survey Topic: Shared Decision Making Population Version: Adult Language: English Users of the CAHPS® Cancer Care Survey are free to incorpora…

277. Chipra-89-Adhd-Behavior-Section-5-Attach-5 (pdf file)
     www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-5.pdf
     February 02, 2012 - methylphenidate (Daytrana [Noven Therapeutics, LLC, Miami, FL]), or OROS methylphenidate (Concerta [Janssen Pharmaceuticals … COMMITTEE Mark Wolraich, MD, Chair – (periodic consultant to Shire, Eli Lilly, Shinogi, and Next Wave Pharmaceuticals … (neurologist; AAP Section on Neurology; Child Neurology Society) (Safety Monitoring Board for Best Pharmaceuticals … and other psychotic symptoms associated with the use of attention-deficit/hyper- activity disorder drugs … Cardiovascular monitor- ing and stimulant drugs for attention- deficit/hyperactivity disorder.

278. ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents (pdf file)
     www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-5-attachment-5.pdf
     February 02, 2012 - methylphenidate (Daytrana [Noven Therapeutics, LLC, Miami, FL]), or OROS methylphenidate (Concerta [Janssen Pharmaceuticals … COMMITTEE Mark Wolraich, MD, Chair – (periodic consultant to Shire, Eli Lilly, Shinogi, and Next Wave Pharmaceuticals … neurologist; AAP Section on Neurology; Child Neurology Society) (Safety Monitoring Board for Best Pharmaceuticals … and other psychotic symptoms associated with the use of attention-deficit/hyper­ activity disorder drugs … Cardiovascular monitor­ ing and stimulant drugs for attention­ deficit/hyperactivity disorder.

279. New Toolkit Can Improve Post-Surgery Complications and Enhance Patient Recovery | Agency for Healthcare Research and Quality
     www.qualitymeasures.ahrq.gov/news/newsletters/e-newsletter/870.html
     June 01, 2023 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

280. Primary Care Practice Facilitation Curriculum Module 26: An Introduction to Electronic Health Records and Meaningful Use (pdf file)
     www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/ncepcr/tools/PCMH/pcpf-module-26-ehr-and-mu.pdf
     September 01, 2015 - Primary Care Practice Facilitation Curriculum Module 26: An Introduction to Electronic Health Records and Meaningful Use Primary Care Practice Facilitation Curriculum Module 26: An Introduction to Electronic Health Records and Meaningful Use Agency for Healthcare Research and Quality Advancing Excelle…